Henry L W, Blasko J C, Griffin T W, Parker R G
Cancer. 1979 Sep;44(3):814-8. doi: 10.1002/1097-0142(197909)44:3<814::aid-cncr2820440304>3.0.co;2-u.
This review analyzes the local control rate of fast neutron beam teletherapy for malignant salivary gland carcinomas compared to conventional photon irradiation at the same institution. Thirty patients with malignant parotid or submaxillary gland tumors were treated with either cobalt-60 (19 patients) or neutrons +/- photons (11 patients). The 19 photon-treated patients were historical controls. No advantage is found for neutrons in patients with tumors less than 3 cm where 100% local control was achieved with either modality. In patients with tumor masses 3-6 cm in size, neutrons demonstrated a possible advantage with a local control rate of 100% (followup, 7-18 months) compared to a control rate of 33% with conventional photon irradiation. Acute treatment-related morbidity was slightly greater in neutron-treated patients, but no long-term complications have been observed to date.
本综述分析了在同一机构中,与传统光子照射相比,快中子束远距离治疗恶性唾液腺癌的局部控制率。30例腮腺或颌下腺恶性肿瘤患者接受了钴-60治疗(19例)或中子±光子治疗(11例)。19例接受光子治疗的患者为历史对照。对于肿瘤小于3 cm的患者,两种治疗方式的局部控制率均达到100%,未发现中子治疗有优势。对于肿瘤大小为3 - 6 cm的患者,中子治疗显示出可能的优势,局部控制率为100%(随访7 - 18个月),而传统光子照射的控制率为33%。中子治疗患者的急性治疗相关发病率略高,但迄今为止未观察到长期并发症。